Physician profile
Jan Cooper
NPI 1104914092
$843.56
in general payments reported to CMS, 2019-2025
13 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.51 · 2023: $152 · 2024: $262 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $301.96 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $123.60 | 2023-2025 | |
| Lilly USA, LLC | $92.98 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $63.07 | 2023-2024 | Trelegy Ellipta |
| Astellas Pharma US INC | $46.24 | 2024 | Veozah |
| Abbvie INC. | $43.74 | 2022-2024 | |
| Exact Sciences Corporation | $43.08 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Corcept Therapeutics | $40.35 | 2024-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $22.12 | 2024 | |
| Novo Nordisk INC | $20.10 | 2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.81 | 2023 | Jardiance |
| Pfizer INC. | $14.55 | 2025 | |
| Dynavax Technologies Corporation | $11.96 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.